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For over a century, since the discovery by Roux and
 
Yersin that sterile culture supernatants of 
 
Corynebacterium
diphtheriae
 
 contained a potent toxin able to reproduce the
lesions caused by diphtheria (1), most pathogenic bacteria
have been considered to be microorganisms able to intoxi-
cate local and distant tissues by secreting toxins in the ex-
tracellular medium. Recently, it has been shown that some
bacteria inject toxic proteins directly into the cytoplasm of
host cells using a specialized, needle-like (2) secretion appa-
ratus (molecular syringe) known as a type III secretion sys-
tem (3, 4). A report in this issue by Ashai et al. (5) and re-
ports from Haas et al. (Haas, R., personal communication),
Segal et al. (6), and our own laboratory (7) now provide
definitive evidence for the existence in 
 
Helicobacter pylori 
 
of
a second type of molecular syringe (type IV secretion sys-
tem) that is also able to inject toxic proteins into eukaryotic
cells. These papers describe the type IV–mediated delivery
into eukaryotic cells and the subsequent tyrosine phosphor-
ylation of CagA, an immunodominant protein of 
 
H. pylori
 
,
encoded by a 40-kb pathogenicity island (
 
cag
 
). The need
for a functional type IV secretion system for CagA translo-
cation into the membrane fraction of host cells and its ty-
rosine phosphorylation is shown at several levels using a va-
riety of isogenic mutants in the 
 
cag
 
 region (7), biochemical
fractionation of the host cell compartments (7), and confo-
cal microscopy (6). In addition, it has been shown that
CagA present in culture supernatants or bacterial cell lysates
is unable to enter eukaryotic cells, indicating that this is not
a function that the soluble protein can perform on its own
(5, 7). Although the correlation between expression of
CagA and 
 
H
 
.
 
 pylori
 
 virulence was described a long time ago
(8, 9), the last seven years have been marked by the frustra-
tion of not finding any role for the CagA protein. Finally,
the concomitant report by four independent laboratories of
a role for CagA sends important messages to the scientific
community. They are summarized below.
 
Type IV and Type III Secretion Systems Are Functionally
 
Equivalent Molecular Syringes.
 
Gram-negative bacteria build
and anchor different extracellular organelles, such as flagella
 
and conjugative pili, using specialized supramolecular struc-
tures. These molecular engines transport the building
blocks of flagella and pili across both the inner and outer
membranes and polymerize the external filamentous struc-
tures by adding new monomers from the inside. In their
evolution, bacteria found it convenient to duplicate the an-
cestral cluster of genes and use one set for further special-
ization as secretion apparatuses to translocate proteins or
protein complexes into host cells (Fig. 1). In other terms,
we may consider the type III and type IV secretion systems
as spin-offs of flagella and conjugative pili, respectively.
The two secretion systems have been extensively reviewed
(4, 10); a list of the bacteria known to contain them is
printed in Table I. Here we will just mention that although
both systems are functionally equivalent and are used to
translocate proteins into mammalian or plant cells, a num-
ber of properties differentiate them: (a) Type III apparatus
and flagella (4) are encoded by 15–35 genes, at least 8 of
which are well conserved in most systems. Type IV system
and conjugative pili (10) are encoded by 11–31 genes, at least
6 of which are well conserved in most of them. No homol-
ogy is present between the genes present in the two systems;
however, both encode proteins with predicted ATPase ac-
tivity. (b) The type III system secretes monomeric proteins
 
with no apparent cleavable 
 
sec
 
-dependent signal sequence.
The type IV system may secrete assembled multimeric pro-
teins such as pertussis toxin that are composed of different
monomers, each having a typical 
 
sec
 
-dependent signal pep-
tide. This suggests that in some cases the proteins may enter
the export machinery after being exported across the inner
membrane by the general secretion system. Type IV secre-
tion may, however, also export across both the inner and
outer membranes nucleoproteins containing proteins and
DNA (as in the case of the Ti plasmid T-DNA of 
 
Agrobacte-
rium tumefaciens
 
). In the case of the CagA protein reported in
references 5–7, it is not known whether this is exported as a
monomer or a more complex structure; however, the ab-
sence of a typical 
 
sec
 
-dependent signal sequence in this pro-
tein suggests that the type IV system assists the translocation
of CagA across both bacterial membranes and also across the
host cell membrane. Finally, both type III and type IV secre-
tion systems are encoded by genes that are clustered, often
present in pathogenicity islands with a GC content different
from the rest of the chromosome and that most likely have
been acquired by horizontal transfer.
 
cag Delivers Multiple Signals.
 
The presence of the 
 
cag
 
pathogenicity island in 
 
H
 
.
 
 pylori 
 
correlates with increased
virulence and disease severity. The findings reported by
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Asahi et al. (5), Haas et al. (personal communication), Segal
et al. (6), and Stein et al. (7) begin to unravel the molecular
mechanisms that may link the presence of 
 
cag
 
 to disease.
Two events are known to happen after 
 
cag
 
-mediated bacte-
 
rium–cell contact: induction of the proinflammatory lym-
phokine IL-8 and CagA tyrosine phosphorylation. The lat-
ter triggers host cell morphological changes such as cell
elongation and spreading, a phenotype similar to that in-
duced in AGS cells by hepatocyte growth factor or bacte-
rial toxins such as cytotoxin necrotizing factor 1, which ac-
tivate the small GTP-binding proteins Rho, Rac, and
Cdc42 (6). Data obtained by mutagenesis of the genes in
the 
 
cag
 
 pathogenicity island (Table II) show that although
both signals require an intact type IV secretion system, they
are delivered by independent effectors. In fact, one of the
mutants (
 
cag
 
F) is able to activate nuclear factor (NF)-
 
k
 
B but
unable to induce IL-8 and CagA tyrosine phosphorylation.
A schematic representation of the possible signaling mecha-
nisms is shown in Fig. 2. Here the 
 
cag 
 
type IV secretion sys-
tem is shown to translocate into the cell an unknown factor
(in the figure it is named “?” for convenience) that activates
the transcription factor NF-
 
k
 
B to induce IL-8 mRNA. As
proposed by Naumann et al. (11), this mechanism is likely
to involve activation of mitogen-activated protein (MAP)
kinases and the transcription factor activator protein (AP)-1.
It is not yet certain whether this pathway needs a yet un-
known effector or whether it is simply activated by the
type IV system itself, which perturbs the membrane. The
second pathway activated by the 
 
cag
 
 system involves the
protein CagA. This protein, as reported in references 5–7,
is translocated into the eukaryotic cells, where it is tyrosine
phosphorylated by a eukaryotic cell kinase (in vitro c-src
and epidermal growth factor receptor protein kinases have
been shown to be able to phosphorylate CagA (5); how-
ever, we do not yet know which kinase is precisely in-
volved in vivo). Once phosphorylated, CagA is likely to
bind an Src homology (SH)2-containing protein (SHC,
phosphatidylinositol 3 kinase, and Nck are possible candi-
dates). This complex can activate multiple pathways: (a) it
may bind directly to N-WASP (neural Wiskott-Aldrich
syndrome protein) and activate it to bind the Arp2/3 actin
nucleator, thus stimulating actin polymerization and pedes-
tal formation, as is the case of the 
 
Shigella flexneri
 
 IcsA (12).
Figure 1. Schematic represen-
tation of a bacterial flagellum (a)
and a conjugative pilus (b) show-
ing their similarity to type III and
type IV secretion systems, respec-
tively. In a, the structural similari-
ties between the core structures of
the flagellar apparatus and the type
III secretion system are sketched.
In b, a hypothetical conjugative
apparatus and a type IV system are
reduced to an artistic impression;
the proteic subunits forming the
structure are not represented.
 
Table I.
 
Bacterial Species with a Fully Annotated Type III 
or Type IV Secretion System
 
Bacterial species Type III Type IV
 
Actinobacillus actinomycetemcomitans
 
—
 
1
 
Agrobacterium tumefaciens
 
—
 
1
 
Bordetella bronchiseptica
 
11
 
Bordetella pertussis
 
11
 
Brucella suis
 
—
 
1
 
Chlamydia
 
 spp.
 
1
 
—
 
Citrobacter rodentium
 
1
 
—
 
E. coli
 
11
 
Enteropathogenic E. coli
 
1
 
—
 
Enterohemorrhagic E. coli
 
1
 
—
 
Erwinia amylovora
 
1
 
—
 
Erwinia chrysanthemi
 
1
 
—
 
Erwinia herbicola
 
 pv.
 
 gysophila
 
1
 
—
 
Erwinia stewartii
 
1
 
—
 
Hafnia alveii
 
1
 
—
 
H. pylori
 
—
 
1
 
Legionella pneumophila
 
—
 
1
 
Pseudomonas aeruginosa
 
1
 
—
 
Pseudomonas syringae
 
1
 
—
 
Ralstonia solanacearum
 
1
 
—
 
Rickettsia prowazekii
 
—
 
1
 
Rhizobium
 
 spp.
 
1
 
—
 
Salmonella enterica
 
1
 
—
 
Shigella
 
 spp.
 
1
 
—
 
Xantomonas
 
 spp.
 
1
 
—
 
Yersinia
 
 spp.
 
1
 
— 
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Table II.
 
List of Genes and Crossed Nomenclature of the cag Pathogenicity Island of H. pylori
 
Nomenclature of 
 
cag
 
 genes according to Properties of single gene inactivation in the 
 
cag
 
 region
Tomb et al.
 
*
 
Akopyants et al.
 
‡
 
Censini et al.
 
§
 
IL-8 secretion NF-
 
k
 
B activation CagA–Ptyr translocation
ND ND G27wt,
 
cag
 
11 1 1
 
ND ND G27
 
D
 
cag
 
22 2
 
HP0520 
 
cag
 
1 ORF6
 
cag
 
z
 
ND ND ND
HP0521 
 
cag
 
2 ORF7
 
cag
 
e2
 
ND ND
HP0522 
 
cag
 
3 ORF8
 
cag
 
d
 
ND ND ND
HP0523 
 
cag
 
4 ORF9
 
cag
 
g
 
ND ND ND
HP0524 
 
cag
 
5 ORF10
 
cag
 
b
 
(
 
virD4
 
)
 
11
 
ND
 
2
 
HP0525 ORF11
 
cag
 
a
 
(
 
virB11
 
)
 
2
 
ND
 
2
 
HP0526 
 
cag
 
6 ORF12
 
cag
 
ZN D N D N D
HP0527 
 
cag
 
7 ORF13
 
cag
 
Y(
 
virB10
 
)
 
2
 
ND
 
2
 
HP0527 
 
cag7 ORF14 ND 2 ND ND
HP0528 cag8 ORF15 cagX(virB9) 2 ND 2
HP0529 cag9 ORF16 cagW(virB8) 2 ND ND
HP0530 cag10 ORF17 cagVN D N D N D
HP0531 cag11 ORF18 cagU 2 ND ND
HP0532 cag12 ORF19 cagT(virB7) 2 ND ND
HP0533 ND ND ND ND ND
HP0534 cag13 ORF20 cagS 2 ND ND
ND ORF21 tnpAN D N D N D
ND ORF22 tnpBN D N D N D
HP0535 cag14 ND cagQN D N D N D
ND ND cagRN D N D N D
HP0536 cag15 ND cagPN D N D N D
ND ND cagON D N D N D
HP0537 cag16 ND cagM 22 2
HP0538 cag17 ND cagN 11 1
HP0539 cag18 ND cagL 22 2
HP0540 cag19 ND cagI 22 2
HP0541 cag20 ND cagH 22 2
HP0542 cag21 ND cagG 22 2
HP0543 cag22 ND cagF 21 2
HP0544 cag23 ND cagE(virB4),
picB
22 2
HP0545 cag24 ND cagD 2i ND 2
HP0546 cag25 ND cagC 2i ND 2
ND ND cagB 2i ND 2
HP0547 cag26 ND cagA 11 2
HP0548 ND cagV ND ND ND
HP0549 glr ND glr ND ND ND
List of genes and crossed nomenclature of the cag pathogenicity island of H. pylori and of the effects on IL-8 secretion, NF-kB activation, and CagA
translocation and tyrosine phosphorylation after single gene inactivation. Type IV homologues are indicated in bold type in parentheses. The CagE
gene was also independently identified by Tummuru et al. as picB (reference 20). The wild-type G27 strain and its mutant derivative Dcag are positive
and negative controls. 
*Reference 17.
‡Reference 18.
§Reference 19.
iAdditional mutant with a cagB–E deletion.590 Commentary
(b) Alternatively, the CagA–P-SH2 protein complex may
activate the Rho family of small, GTP-binding proteins
(Cdc42, Rac, or Chp), which control the organization of
the actin cytoskeleton. This pathway could also cause actin
polymerization and pedestal formation by activating N-WASP
(13). (c) The CagA–P-SH2 protein complex may trigger a
signaling cascade, possibly via the MAP pathway, which
may induce transcription of nuclear genes. Although there
is plenty of evidence that actin polymerization occurs and
therefore one or both of the mechanisms mentioned in (a)
or (b) must be activated by CagA–P, there is not yet any
evidence for the pathway mentioned in (c). However, the
increased frequency of gastric cancer in patients infected by
cag1 H. pylori strains and the H. pylori–dependent MALT
(mucosal-associated lymphoid tissue) lymphoma suggest
that nuclear signaling is a possible mechanism of pathogen-
esis. Whether the delivery of CagA into host cells facilitates
antigen presentation, thus explaining why CagA is the im-
munodominant antigen of H. pylori, is an intriguing possi-
bility that deserves further investigation.
Tyrosine Phosphorylation of Injected Bacterial Proteins Is an
Emerging Signaling Mechanism. Before CagA, another pro-
tein was described as injected into mammalian cells and ty-
rosine phosphorylated by eukaryotic cell kinases. This is the
translocated intimin receptor (Tir) of enteropathogenic
Escherichia coli that, after injection and tyrosine phosphory-
lation, serves as a receptor for “intimin” adhesin (Fig. 3;
reference 14). CagA is the second example of a bacterial
protein that is shown to be injected into eukaryotic cells
and then tyrosine phosphorylated by eukaryotic cell ki-
nases. During Chlamydia infection, it has been found that
eukaryotic cells can also phosphorylate a bacterial protein at
serine/threonine residues (15). The discovery in different
bacteria of this new type of cell intoxication mechanism
suggests that many more examples will emerge in the near
future.
The use of phosphotyrosines by bacterial pathogens is
not surprising; pathogenic bacteria are known to target
most crucial regulatory circuits of the eukaryotic cell. Large
and small GTP-binding proteins that act on most of the
cellular signal transduction pathways are targets of many
classical toxins and toxins injected by the type III secretion
system. Now that bacterial virulence factors have been
shown to also target tyrosine phosphorylation, the other
Figure 2. After type IV contact and CagA
translocation, two independent signaling path-
ways are induced in the host cell.591 Covacci and Rappuoli
major cellular signaling mechanism, we can probably con-
clude that bacteria manage to target virtually all key regula-
tory circuits of eukaryotic cells. It is interesting that in this
case the targets are not the key enzymes such as kinases or
phosphatases, which would have a more pleiotropic effect.
Rather, the action is very precise: bacteria inject molecules
that appear as host proteins but that act as Trojan horses con-
taining a bacterial hidden core message that allows the mi-
croorganism to take control over the host cell. Surprisingly,
vaccinia virus exploits similar mechanisms of forced actin po-
lymerization—mediated by tyrosine phosphorylation of the
viral protein A36R—to spread from cell to cell (16).
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